Back to results
US 2022/0177514 A1Published application
A method for functionalization of an aromatic amino acid or a nucleobase
AssigneesCF Plus Chemicals s.r.o., Ustav Organicke Chemie A Biochemie Av Cr, V.V.I., Mikrobiologicky Ustav Av Cr, V.V.I.
InventorsVaclav MATOUSEK, Petr BEIER, Petr NOVAK
Life of this patent
Estimating the term…
Abstract
A method for functionalization of an aromatic amino acid or a nucleobase with a fluoroalkyl-containing moiety RF, wherein the aromatic amino acid is reacted in the presence of at least one reductant with at least one hypervalent iodine fluoroalkyl reagent carrying the floroalkyl-containing moiety RF is disclosed. Novel hypervalent iodine fluoroalkyl reagents is also disclosed.
Claims11
1:
- A method for functionalization of an aromatic amino acid or a nucleobase with a fluoroalkyl-containing moiety RF, wherein the aromatic amino acid or the nucleobase is reacted in the presence of at least one reductant with at least one hypervalent iodine fluoroalkyl reagent,
- wherein the hypervalent iodine fluoroalkyl reagent is of general formula 1
- wherein
- R1 is selected from H, C1-C4 alkyl, Me(OCH2CH2)nO, wherein n=1-10,
- X1 is not present or is selected from chloride, tetrafluoroborate, hexafluorophosphate, trifluoromethanesulfonate, methanesulfonate, toluenesulfonate, fluoride, bromide, (F(CF2)sSO2)2N−, wherein s=1 to 4, C1-C6 carboxylate, fluorinated C1-C6 carboxylate, hexafluoroantimonate;
- A1 is not present or is selected from
- carbonyl group (C═O),
- R2—C—R3, wherein R2 and R3 are independently selected from fluorine, chlorine, hydrogen, CF3, C1-C4 alkyl, phenyl, phenyl substituted by fluorine, chlorine and/or C1-C4 alkyl, omega-methoxy-(C1-C4)alkyl;
- or R2 and R3 together with the carbon atom to which they are bound form 1,1-cyclobutylene, 1,1-cyclopentylene, 1,1-cyclohexylene, 1,1-(4-oxacyclohexylene);
- A2 is not present or is selected from
- hydroxyl group (OH),
- oxygen (—O—),
- C1-4 alkoxy,
- OSiR4R5R6, wherein R4,R5,R6 are independently selected from methyl, ethyl, n-propyl, i-propyl and phenyl;
- R7N, wherein R7 is selected from C1-10 alkyl, phenyl-substituted C1-10 alkyl, 4-chlorophenyl-substituted C1-10 alkyl, and CH3(OCH2CH2)n;
- R8CO—, wherein R8 is selected from C1-10 alkyl, phenyl-substituted C1-10 alkyl, CH3(OCH2CH2)o—, wherein o=1-10, Cl−Me3N+(CH2)p—, wherein p=1-10, —(CX2)mCOOQ, —(CX2)mSO3Q, wherein m=2-3, -phenyl-SO3Q, -phenyl-COOQ, —(CX2)mCOO—, —(CX2)mSO3—, wherein m=2-3, -phenyl-SO3—, -phenyl-COO—,
- X2═F or Cl, X3═H, CH3, F or Cl,
- Q is selected from lithium, sodium, potassium, rubidium, cesium, tetra (C1-C4 alkyl, phenyl, benzyl) ammonium, tri (C1-C4 alkyl, phenyl, benzyl) pyridinium;
- R9C(O)O—, wherein R9 is selected from C1-10 alkyl, phenyl-substituted C1-10 alkyl, CH3(OCH2CH2)o—, wherein o=1-10, Cl−Me3N+(CH2)p—, wherein p=1-10, —(CX2)mCOOQ, —(CX2)mSO3Q, wherein m=2-3, -phenyl-SO3Q, -phenyl-COOQ, —(CX2)mCOO—, —(CX2)mSO3—, wherein m=2-3, -phenyl-SO3—, -phenyl-COO—,
- X2═F or Cl, X3═H, CH3, F or Cl,
- Q is selected from lithium, sodium, potassium, rubidium, cesium, tetra (C1-C4 alkyl, phenyl, benzyl) ammonium, tri (C1-C4 alkyl, phenyl, benzyl) pyridinium;
- RF is —CF2-A3-A4, wherein
- A3 is not present and A4 is fluorine, or phenylsulfanyl (PhS) group, or
- A3 is CF2 and A4 is fluorine, C1-10 perfluoroalkyl, phenoxy, C1-10 alkoxy, phenylsulfanyl, N-imidazolyl, N-pyrazolyl, N-benzimidazolyl, N-triazoyl, N-(2-methyl)imidazolyl, CH3(OCH2CH2)nO, where n=1-10, Cl−MeH2N+(CH2)m wherein r=1-10, Cl−MeH2N+(CH2)2-phenyloxy, C1-10 alkyl, ethenyl, ethynyl, omega-azido C1-10 alkyl, omega-amino C1-10 alkyl, omega-ethynyl C1-10 alkyl, C1-10 alkylthio, phenyl, chloro, bromo, iodo, azido, nitro, C1-10 alkoxycarbonyl-substituted phenyl, C2-10 alkenyl, C2-10 alkyl omega substituted with SO2F, N-succinimide-O—C(O)—, methyldiaziridine, trifluoromethyldiaziridine, rhodamine, fluorescein or coumarin;
- aryl p-substituted with N-succinimide-O—C(O)—, rhodamine, fluorescein or coumarin, phenoxy p-substituted with N-succinimide-O—C(O)—, rhodamine, fluorescein or coumarin, and 2-(aryliodanyl)-1,1,2,2-tetrafluoroethyl;
- in alkyl chains, two neighboring carbon atoms may be replaced by a methylamido group (—N(Me)-C(O)—) and/or by a phenyl group.
23 more elements
2:
- The method of claim 1, wherein in formula 1:
- A1 is present, A2 is a bivalent substituent, and X1 is not present;
- or
- A1 is present, A2 is a monovalent substituent bound to A1, and X1 is present.
1 more element
3:
- The method of claim 1, wherein the aromatic amino acid is selected from phenylalanine, tryptophan, tyrosine, histidine.
4:
- The method of claim 1, wherein the aromatic amino acid is tryptophan.
5:
- The method of claim 1, wherein the nucleobase is cytosine.
6:
- The method of claim 1, wherein the reductant is selected from a group consisting of sodium ascorbate, potassium ascorbate, calcium ascorbate, magnesium ascorbate, esters of ascorbic acid with carboxylic acids of the formula R10CO2H wherein R10 is C1-18 alkyl, sodium sulphite, sodium dithionite, tetrakis(dimethylamino)ethylene, sodium phosphite, sodium hypophosphite, and sodium hydroxymethanesulfinate.
7:
- The method of claim 1, wherein the reductant is used in an amount of 0.5-1.0 equivalents, preferably of 0.9-1.1 equivalents, relative to the hypervalent iodine fluoroalkyl reagent.
8:
- The method of claim 1, wherein aromatic amino acids incorporated in a protein are reacted in the presence of at least one reductant with at least one hypervalent iodine fluoroalkyl reagent, and subsequently it is detected which amino acids are fluoroalkylated and these amino acids are then determined to be present on the solvent-exposed surface of the protein.
9:
- The method of claim 1, wherein the hypervalent iodine fluoroalkyl reagent is selected from the group consisting of the following reagents:
10:
- A hypervalent iodine fluoroalkyl reagent of general formula 1-1
- wherein
- R1 is selected from H, C1-C4 alkyl, Me(OCH2CH2)nO, wherein n=1-10,
- X1 is not present or is selected from chloride, tetrafluoroborate, hexafluorophosphate, trifluoromethanesulfonate, methanesulfonate, toluenesulfonate, fluoride, bromide, (F(CF2)sSO2)2N−, wherein s=1 to 4, C1-C6 carboxylate, fluorinated C1-C6 carboxylate, hexafluoroantimonate;
- A1 is not present or is selected from
- carbonyl group (C═O),
- R2—C—R3, where R2 and R3 are independently selected from fluorine, chlorine, hydrogen, CF3, C1-C4 alkyl, phenyl, phenyl substituted by fluorine, chlorine and/or C1-C4 alkyl, omega-methoxy-(C1-C4)alkyl;
- or R2 and R3 together with the carbon atom to which they are bound form 1,1-cyclobutylene, 1,1-cyclopentylene, 1,1-cyclohexylene, 1,1-(4-oxacyclohexylene);
- A2 is not present or is selected from
- hydroxyl group (OH),
- oxygen (—O—),
- C1-4 alkoxy,
- OSiR4R5R6, wherein R4,R5,R6 are independently selected from methyl, ethyl, n-propyl, i-propyl and phenyl;
- R7N, wherein R7 is selected from C1-10 alkyl, phenyl-substituted C1-10 alkyl, 4-chlorophenyl-substituted C1-10 alkyl, and CH3(OCH2CH2)n;
- R8CO—, wherein R8 is selected from C1-10 alkyl, phenyl-substituted C1-10 alkyl, CH3(OCH2CH2)o—, wherein o=1-10, Cl−Me3N+(CH2)p—, wherein p=1-10, —(CX2)mCOOQ, —(CX2)mSO3Q, wherein m=2-3, -phenyl-SO3Q, -phenyl-COOQ, —(CX2)mCOO—, —(CX2)mSO3—, wherein m=2-3, -phenyl-SO3—, -phenyl-COO—,
- X2═F or Cl, X3═H, CH3, F or Cl,
- Q is selected from lithium, sodium, potassium, rubidium, cesium, tetra (C1-C4 alkyl, phenyl, benzyl) ammonium, tri (C1-C4 alkyl, phenyl, benzyl) pyridinium;
- R9C(O)O—, wherein R9 is selected from C1-10 alkyl, phenyl-substituted C1-10 alkyl, CH3(OCH2CH2)o—, wherein o=1-10, Cl−Me3N+(CH2)p—, wherein p=1-10, —(CX2)mCOOQ, —(CX2)mSO3Q, wherein m=2-3, -phenyl-SO3Q, -phenyl-COOQ, —(CX2)mCOO—, —(CX2)mSO3—, wherein m=2-3, -phenyl-SO3—, -phenyl-COO—,
- X2═F or Cl, X3═H, CH3, F or Cl,
- Q is selected from lithium, sodium, potassium, rubidium, cesium, tetra (C1-C4 alkyl, phenyl, benzyl) ammonium, tri (C1-C4 alkyl, phenyl, benzyl) pyridinium;
- RF is —CF2-A3-A4, wherein
- A3 is not present and A4 is fluorine, or phenylsulfanyl (PhS) group, or
- A3 is CF2 and A4 is fluorine, C1-10 perfluoroalkyl, phenoxy, C1-10 alkoxy, phenylsulfanyl, N-imidazolyl, N-pyrazolyl, N-benzimidazolyl, N-triazoyl, N-(2-methyl)imidazolyl, CH3(OCH2CH2)nO, where n=1-10, Cl−MeH2N+(CH2)r, wherein r=1-10, Cl−MeH2N+(CH2)2-phenyloxy, C1-10 alkyl, ethenyl, ethynyl, omega-azido C1-10 alkyl, omega-amino C1-10 alkyl, omega-ethynyl C1-10 alkyl, C1-10 alkylthio, phenyl, chloro, bromo, iodo, azido, nitro, C1-10 alkoxycarbonyl-substituted phenyl, C2-10 alkenyl, C2-10 alkyl omega substituted with SO2F, N-succinimide-O—C(O)—, methyldiaziridine, trifluoromethyldiaziridine, rhodamine, fluorescein or coumarin;
- aryl p-substituted with N-succinimide-O—C(O)—, rhodamine, fluorescein or coumarin, phenoxy p-substituted with N-succinimide-O—C(O)—, rhodamine, fluorescein or coumarin, and 2-(aryliodanyl)-1,1,2,2-tetrafluoroethyl;
- in alkyl chains, two neighboring carbon atoms may be replaced by a methylamido group (—N(Me)-C(O)—) and/or by a phenyl group,
- provided that:
- A2 is not —O— or —OH, when:
- A1 is C═O or R2—C—R3, wherein R2 and R3 are methyls;
- A2 is not —O—C(═O)CH3, when:
- RF is CF3 and A1 is C═O or R2—C—R3, wherein R2 and R3 are methyls;
- A2 is not —O— or —OH, when:
- X1 is not present, RF is CF3 and A1 is R2—C—R3, wherein R2 and R3 are selected from alkyl and CF3 or wherein R2 is methyl and R3 is phenyl or R2 and R3 together form 1,1-cyclohexylene;
- A2 is not —O— or —OH, when:
- X1 is not present, RF is selected from perfluoroethyl, perfluoropropyl, perfluorobutyl, perfluorohexyl or perfluorooctyl, A1 is R2—C—R3, wherein R2 is methyl and R3 is phenyl or isopropyl;
- A2 is not R7N, wherein R7 is selected from C1-10 alkyl, phenyl-substituted C1-10 alkyl, when:
- X1 is not present, RF is CF3 and A1 is C═O.
33 more elements
11:
- A hypervalent iodine fluoroalkyl reagent selected from the following compounds